Inventor · disambiguated record
Johann Leban
Also filed as: LEBAN JOHANN · LEBAN JOHANN J · LEBAN JOHANN JAKOB
22 granted patents·14 pending applications·413 citations·filing 1988–2018
95Inventor score
Top patents by PatentIndex Score
36 records- 0196US7365094B2Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents4SC AG·Filed 2003·Granted Apr 29, 2008·92 cites·7 claims
- 0295US7247736B2Method of identifying inhibitors of DHODH4SC AG·Filed 2004·Granted Jul 24, 2007·90 cites·10 claims
- 0390US7071355B2Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents4 SC AG·Filed 2003·Granted Jul 4, 2006·84 cites·23 claims
- 0488US7601745B2Heterocyclic NF-kB inhibitors4SC AG·Filed 2006·Granted Oct 13, 2009·15 cites·2 claims
- 0583US8354433B2Anti-inflammatory agents as virostatic compounds4SC AG·Filed 2010·Granted Jan 15, 2013·12 cites·24 claims
- 0682US9951050B2Method of inhibiting DYRK1B4SC DISCOVERY GMBH·Filed 2014·Granted Apr 24, 2018·7 cites·18 claims
- 0781US6235717B1Pharmaceutical compoundsGLAXO WELLCOME INC·Filed 1994·Granted May 22, 2001·59 cites·17 claims
- 0878US7812041B2Heterocyclic NF-κB inhibitors4SC AG·Filed 2005·Granted Oct 12, 2010·4 cites·9 claims
- 0973US10005769B22,3-dihydrobenzofuran-5YL compounds as DYRK kinase inhibitors4SC DISCOVERY GMBH·Filed 2014·Granted Jun 26, 2018·3 cites·39 claims
- 1073US8354436B2IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation4SC DISCOVERY GMBH·Filed 2012·Granted Jan 15, 2013·3 cites·20 claims
- 1172US7531517B2Inhibitors of cancer cell, T-cell and keratinocyte proliferation4SC AG·Filed 2006·Granted May 12, 2009·1 cites·2 claims
- 1271US8653138B2Calcium salts of compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agentsAMMENDOLA ALDO·Filed 2011·Granted Feb 18, 2014·5 cites·19 claims
- 1367US9580438B2Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and CNS disorders4SC DISCOVERY GMBH·Filed 2013·Granted Feb 28, 2017·1 cites·26 claims
- 1466US8592456B2IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammationLEBAN JOHANN·Filed 2012·Granted Nov 26, 2013·2 cites·20 claims
- 1563US5620959ABombesin antagonistsGLAXO WELLCOME INC·Filed 1994·Granted Apr 15, 1997·22 cites·8 claims
- 1663US2010048574A1NOVEL HETEROCYCLIC NF-kB INHIBITORS4SC AG·Filed 2009·Application pending·0 cites
- 1762US2010004258A1Novel Heterocyclic NF-kB Inhibitors4SC AG·Filed 2009·Application pending·0 cites
- 1858US2010048583A1Novel Heterocyclic NF-kB Inhibitors4SC AG·Filed 2009·Application pending·0 cites
- 1957US10633369B2Method of inhibiting DYRK1B4 SC AG·Filed 2018·Granted Apr 28, 2020·0 cites·14 claims
- 2057US2009176716A1Inhibitors of cancer cell, t-cell and keratinocyte proliferationLEBAN JOHANN·Filed 2009·Application pending·0 cites
- 2152US2010267717A1Novel Heterocyclic NF-kB Inhibitors4SC AG·Filed 2007·Application pending·0 cites
- 2251US7317030B2Compounds as inhibitors of cell proliferation and viral infections4SC AG·Filed 2005·Granted Jan 8, 2008·0 cites·8 claims
- 2349US2008241100A1Pharmaceutical composition comprising a cytokineSTROBL STEFAN·Filed 2008·Application pending·0 cites
- 2449US2011263486A1Inhibitors of Cancer Cell, T-Cell and Keratinocyte Proliferation4SC AG·Filed 2011·Application pending·0 cites
- 2548US2009304632A1HETEROCYCLIC NF-kB INHIBITORSLEBAN JOHANN·Filed 2009·Application pending·0 cites
- 2647US4943627APeptides involved in the pathogenesis of HIV infectionBIOGEN INC·Filed 1988·Granted Jul 24, 1990·7 cites·3 claims
- 2747US2007224672A1Method of Identifying Inhibitors of DHODHLEBAN JOHANN·Filed 2007·Application pending·0 cites
- 2846US10221147B2Heterocyclic compounds with working memory enhancing activityRED BULL GMBH·Filed 2017·Granted Mar 5, 2019·0 cites·14 claims
- 2946US2012028985A1Combinational therapy for treating autoimmune diseaseGROEPPEL MANFRED·Filed 2009·Application pending·0 cites
- 3046US2011052532A1Pharmaceutical composition comprising a cytokineSTROBL STEFAN·Filed 2010·Application pending·0 cites
- 3145US2007219190A1Heterocyclic NF-kB Inhibitors4SC AG·Filed 2007·Application pending·0 cites
- 3244US2017240556A1Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and cns disorders4SC DISCOVERY GMBH·Filed 2017·Application pending·0 cites
- 3340US11091490B23-amino-1,5-dihydro-pyrazolo[3,4-d]pyrimidin-4-ones as cyclin dependent kinase inhibitorsONCOTYROL CENTER FOR PERSONALIZED CANCER MEDICINE GMBH·Filed 2017·Granted Aug 17, 2021·0 cites·4 claims
- 3440US5670482ANeuropeptide Y antagonistsGLAXO WELLCOME INC·Filed 1993·Granted Sep 23, 1997·6 cites·16 claims
- 3540US2012022068A1NOVEL HETEROCYCLIC NF-kB INHIBITORSLEBAN JOHANN·Filed 2011·Application pending·0 cites
- 3636US8106048B2Heterocyclic NF-κB inhibitorsLEBAN JOHANN·Filed 2005·Granted Jan 31, 2012·0 cites·16 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →